About Us
A platform that puts the power of sickle cell management back in your hands.
Sikila is on a mission to transform the sickle cell journey by equipping warriors with an advanced, intuitive tracking and community platform. Sickle cell warriors deserve better, and our tools are built to guide you at every step of your health journey.
After months of research, design, and collaboration with the community, we have officially launched the Sikila app. It is a seamless, secure companion that tells you exactly what you need to know about your symptoms, triggers, and patterns - right at your fingertips.
Our goal is to equip users with accurate, private data about their own bodies, enabling them to make informed decisions and advocate for themselves without the guesswork.
Driven by Data,
Not Guesswork
We push the limits of technology to create a health companion of premium quality. Whether it’s logging pain or tracking hydration, we turn your daily habits into actionable insights.
Built by the Community,
For the Community
No tall claims. No frills. No false promises. We actively solicit user feedback and incorporate it directly into our product development to ensure Sikila serves the people who need it most.
Empowering Warriors to
Advocate for Themselves
We understand that knowledge is the key to holistic well-being. We give you the exact data you need to communicate effectively with doctors, caregivers, and your support system.
Privacy First
Your health data is entirely under your control. All information is encrypted, and you decide exactly what to share, and who to share it with.
Our Team
Teju
Sanusi
Steven
Zgaljic
(Founding Design Director)(CTO Advisor)
Leuvon van
der Leeuw
Fauzia van
der Leeuw
(Strategy & Research/ Co-Founder)(Product & Ops / Co-Founder)Our Technical Vision
Next-Generation Infrastructure
Sikila is building towards a future powered by advanced Machine Learning and Predictive AI. Our engineering roadmap focuses on leveraging these technologies to move SCD care from reactive to preventative. By building on digital-native, FHIR-compliant architecture, we ensure our platform is ready for seamless interoperability with global clinical systems.
A Sustainable, Scalable Model
We are a commercial SaaS platform engineered for long-term impact. Our phased roadmap includes our B2C patient-focused application, alongside a B2B enterprise model designed to partner with researchers and institutions. By providing structured, anonymised Real-World Evidence (RWE), we aim to accelerate the next generation of Sickle Cell treatments.